中医临床研究
中醫臨床研究
중의림상연구
Clinical Journal of Chinese Medicine
2015年
31期
84-85
,共2页
肾康注射液%复方α-酮酸%慢性肾衰
腎康註射液%複方α-酮痠%慢性腎衰
신강주사액%복방α-동산%만성신쇠
The Shenkang injection%Compoundα-keto acid%Chronic renal failure
目的:观察肾康注射液联合复方α-酮酸治疗慢性肾功能衰竭的效果。方法:选取2013年6月-2014年6月本院收治的慢性肾衰患者102例为观察对象,将其随机分为观察组与对照组,每组各51例。对照组予复方α-酮酸治疗,观察组在对照组的基础上予肾康注射液治疗,比较两组肾脏功能指标、临床疗效和不良反应。结果:观察组治疗后的Scr、BUN水平低于对照组且Ccr水平高于对照组,比较差异均有统计学意义(P<0.05);观察组总有效率为94.12%,高于对照组的74.5%,比较差异具统计学意义(P<0.05)。结论:肾康注射液联合复方α-酮酸治疗慢性肾衰的效果显著。
目的:觀察腎康註射液聯閤複方α-酮痠治療慢性腎功能衰竭的效果。方法:選取2013年6月-2014年6月本院收治的慢性腎衰患者102例為觀察對象,將其隨機分為觀察組與對照組,每組各51例。對照組予複方α-酮痠治療,觀察組在對照組的基礎上予腎康註射液治療,比較兩組腎髒功能指標、臨床療效和不良反應。結果:觀察組治療後的Scr、BUN水平低于對照組且Ccr水平高于對照組,比較差異均有統計學意義(P<0.05);觀察組總有效率為94.12%,高于對照組的74.5%,比較差異具統計學意義(P<0.05)。結論:腎康註射液聯閤複方α-酮痠治療慢性腎衰的效果顯著。
목적:관찰신강주사액연합복방α-동산치료만성신공능쇠갈적효과。방법:선취2013년6월-2014년6월본원수치적만성신쇠환자102례위관찰대상,장기수궤분위관찰조여대조조,매조각51례。대조조여복방α-동산치료,관찰조재대조조적기출상여신강주사액치료,비교량조신장공능지표、림상료효화불량반응。결과:관찰조치료후적Scr、BUN수평저우대조조차Ccr수평고우대조조,비교차이균유통계학의의(P<0.05);관찰조총유효솔위94.12%,고우대조조적74.5%,비교차이구통계학의의(P<0.05)。결론:신강주사액연합복방α-동산치료만성신쇠적효과현저。
Objective:To observe clinical effects of the Shenkang injection plus compoundα-keto acid on chronic renal failure. Methods:102 patients from June 2013 to June 2014 in our hospital were selected as observed objects and divided into the observation group and the control group, 51 cases for each. The control group was treated with compoundα-keto acid. The observation group was treated with the Shenkang injection more. Renal function parameters, clinical efifcacy and adverse reactions in two groups were compared. Results:After the treatment, Scr levels and BUN levels in the observation group were lower than those in the control group. Ccr level in the observation group was higher than that in the control group. The difference was statistically signiifcant. The total efifciency in the observation group was 94.12%, higher than 74.5%in the control group, P<0.05. Conclusion:The Shenkang injection plus compoundα-keto acid was signiifcantly effective on chronic renal failure.